Boston Scientific: Beating Expectations, Stock Dips Anyway

Boston Scientific just crushed its third-quarter earnings, reporting a 20% sales jump to $5.07 billion and exceeding profit expectations! Fueled by surging demand for medical devices, the company's growth is accelerating, and it's projecting even stronger sales ahead. Despite the impressive numbers, the stock dipped slightly, but with rising efficiency and a solid track record, Boston Scientific remains a healthcare stock to watch.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.